Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Cognitive Behavioral Therapy for Depression and Anxiety, Response Rates and Adverse Events in Patients with Locoregional Advanced Nasopharyngeal Carcinoma.
Liu F, Fu SN, Chen YZ, Yan OY, Tong F, Peng WL, Zou R, Wen MN, Jiang L, Ma HZ, He Q, Liu L, Yang H, Huang XF, Han YQ, Wang H, Liu XH. Liu F, et al. Among authors: ma hz. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211006179. doi: 10.1177/15347354211006179. Integr Cancer Ther. 2021. PMID: 33784875 Free PMC article.
Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial.
Fu S, Li Y, Han Y, Wang H, Chen Y, Yan O, He Q, Ma H, Liu L, Liu F. Fu S, et al. Among authors: ma h. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):101-113. doi: 10.1016/j.ijrobp.2021.12.175. Epub 2022 Jan 22. Int J Radiat Oncol Biol Phys. 2022. PMID: 35074433 Clinical Trial.
Erratum to: Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial.
Fu S, Li Y, Han Y, Wang H, Chen Y, Yan O, He Q, Ma H, Liu L, Liu F. Fu S, et al. Among authors: ma h. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):1055-1056. doi: 10.1016/j.ijrobp.2022.07.013. Epub 2022 Nov 14. Int J Radiat Oncol Biol Phys. 2022. PMID: 36395793 No abstract available.
Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases.
Li L, Huang Z, Chen Y, Ma H, Chen X, Yan H, Qin H, Zhang Y, Zhang X, Jiang W, Wang Z, Zhang L, Zeng F, Zhou Z, Pu X, Yang N, Zeng L, Zhang Y. Li L, et al. Among authors: ma h. Heliyon. 2024 Dec 7;10(24):e40703. doi: 10.1016/j.heliyon.2024.e40703. eCollection 2024 Dec 30. Heliyon. 2024. PMID: 39759323 Free PMC article.
N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target.
Quan C, Belaydi O, Hu J, Li H, Yu A, Liu P, Yi Z, Qiu D, Ren W, Ma H, Gong G, Ou Z, Chen M, Sun Y, Chen J, Zu X. Quan C, et al. Among authors: ma h. Front Immunol. 2021 Aug 30;12:697026. doi: 10.3389/fimmu.2021.697026. eCollection 2021. Front Immunol. 2021. PMID: 34526985 Free PMC article. Review.
20,237 results
You have reached the last available page of results. Please see the User Guide for more information.